AVANT GARDE

A randomized, double-blind, parallel-group, placebocontrolled, multinational clinical trial to evaluate the efficacy of Aliskiren and valsartan versus placebo in lowering levels on NT-proBNP in stabilized patients post acute coronary syndromes

Stage
klaar
Medicine
aliskiren
Population
ASCVD
Phase
II
First Patient In
-
Last Patient In
-
Last Patient Last Visit
-
The page has expired.